Skip to main content
. 2011 Jul 28;68(1):39–53. doi: 10.1007/s00228-011-1095-3

Table 5.

Clinical efficacy rates stratified by fAUC0−24/MIC obtained at the phase III study

fAUC0−24/MIC (h) Efficacy rate (cure/number of patients) 95% confidence interval for efficacy rate
>30 91.8% (56/61) 81.9 –97.3%
≤30 40.0% (2/5) 5.3– 85.3%
>28 a 91.8% (56/61) 81.9 –97.3%
≤28 40.0% (2/5) 5.3– 85.3%

fAUC0−24/MIC, Unbound AUC/minimum inhibitory dose ratio

aClassification and regression tree (CART)-derived split